Verition Fund Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-165,700
Closed -$449K 2768
2025
Q4
$449K Sell
165,700
-2,297
-1% -$7.54K ﹤0.01% 2741
2025
Q3
$711K Sell
167,997
-10,835
-6% -$47.6K ﹤0.01% 2794
2025
Q2
$891K Buy
178,832
+37,535
+27% +$163K ﹤0.01% 2562
2025
Q1
$623K Buy
141,297
+66,012
+88% +$310K ﹤0.01% 2432
2024
Q4
$350K Buy
75,285
+61,250
+436% +$337K ﹤0.01% 2684
2024
Q3
$97.4K Sell
14,035
-31,562
-69% -$248K ﹤0.01% 2999
2024
Q2
$356K Buy
45,597
+25,200
+124% +$187K ﹤0.01% 2248
2024
Q1
$145K Buy
+20,397
New +$135K ﹤0.01% 2545
2021
Q3
Sell
-16,003
Closed -$576K 2050
2021
Q2
$576K Buy
+16,003
New +$591K 0.01% 1026

Other funds holding GDRX

Verition Fund Management's GDRX Position: Q1 2026 in Review

Verition Fund Management sold out of GoodRx Holdings (GDRX) in Q1 2026, closing a stake of 165,700 shares — an estimated $449K sold.

Verition Fund Management first reported a position in GDRX in Q2 2021 and held it in 9 quarters. The position peaked at $891K in Q2 2025. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Verition Fund Management reported no remaining GoodRx Holdings position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 165,700 GoodRx Holdings shares in Q1 2026, an estimated $449K.
  • Verition Fund Management first reported a position in GoodRx Holdings in Q2 2021 and held it in 9 quarters.
  • Verition Fund Management's GoodRx Holdings position peaked at $891K in Q2 2025.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.